Showing results (331-340 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|October 20, 2018
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational studyMaximilian J Hochmair, Alessandro Morabito, Desiree Hao, et al.
Future Oncology (London, England)|February 5, 2014
Cancer healthcare: change is the only constantBen Holland, Francesca Lake
Future Oncology (London, England)|February 5, 2014
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncologyEmanuel Stutz, Oliver Gautschi, Martin F Fey, et al.
Future Oncology (London, England)|February 25, 2014
Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancerAdetunji T Toriola, Egle Tolockiene, Helena Schock, et al.
Future Oncology (London, England)|April 7, 2017
Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysisJiamao Lin, Cheng Li, Chenyue Zhang, et al.
Future Oncology (London, England)|January 24, 2017
Preparation and biological evaluation of 99mTc-HYNIC-(Ser)3-D4 peptide for targeting and imaging of non-small-cell lung cancerMona Haddad Zahmatkesh, Seyed Mohammad Abedi, Seyed Jalal Hosseinimehr
Future Oncology (London, England)|June 4, 2008
Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignanciesAmanda K Beck, Harvey I Pass, Michele Carbone, et al.
Future Oncology (London, England)|June 4, 2008
Current status of therapy for chronic myeloid leukemia: a review of drug developmentSwami Padmanabhan, Saritha Ravella, Tyler Curiel, et al.
Future Oncology (London, England)|August 14, 2019
Fruquintinib and its use in the treatment of metastatic colorectal cancerYanhong Deng, Xiaomin Li
Future Oncology (London, England)|March 30, 2019
GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60Cong Zhou, Ranran Pan, Bin Li, et al.
Pageof 451